Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Acetonide for Post-craniotomy Pain
NCT06069804Phase 4Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2023
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triamcinolone acetonide in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Cumulative sufentanil consumption within 48 hours postoperatively. Started Oct 2023; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06069804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06069804.